NO20035224D0 - Oftalmisk pirenzepingel - Google Patents

Oftalmisk pirenzepingel

Info

Publication number
NO20035224D0
NO20035224D0 NO20035224A NO20035224A NO20035224D0 NO 20035224 D0 NO20035224 D0 NO 20035224D0 NO 20035224 A NO20035224 A NO 20035224A NO 20035224 A NO20035224 A NO 20035224A NO 20035224 D0 NO20035224 D0 NO 20035224D0
Authority
NO
Norway
Prior art keywords
pirenzepel
ophthalmic
ophthalmic pirenzepel
Prior art date
Application number
NO20035224A
Other languages
English (en)
Norwegian (no)
Inventor
Harun Takruri
Original Assignee
Valley Forge Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valley Forge Pharmaceuticals filed Critical Valley Forge Pharmaceuticals
Publication of NO20035224D0 publication Critical patent/NO20035224D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20035224A 2001-05-25 2003-11-24 Oftalmisk pirenzepingel NO20035224D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29373101P 2001-05-25 2001-05-25
PCT/US2002/013823 WO2002096418A1 (fr) 2001-05-25 2002-05-01 Gel ophtalmique de pirenzepine

Publications (1)

Publication Number Publication Date
NO20035224D0 true NO20035224D0 (no) 2003-11-24

Family

ID=23130330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035224A NO20035224D0 (no) 2001-05-25 2003-11-24 Oftalmisk pirenzepingel

Country Status (17)

Country Link
US (2) US20040137069A1 (fr)
EP (1) EP1397132A4 (fr)
JP (1) JP2004531569A (fr)
KR (1) KR20040018380A (fr)
CN (1) CN1509172A (fr)
BR (1) BR0210013A (fr)
CA (1) CA2447562A1 (fr)
EC (1) ECSP044862A (fr)
HU (1) HUP0304071A2 (fr)
IL (1) IL158904A0 (fr)
MX (1) MXPA03010655A (fr)
NO (1) NO20035224D0 (fr)
NZ (1) NZ529615A (fr)
PL (1) PL366924A1 (fr)
RU (1) RU2297831C2 (fr)
WO (1) WO2002096418A1 (fr)
ZA (1) ZA200309791B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005263577C1 (en) * 2004-07-16 2010-08-26 Proteosys Ag Muscarinic antagonists with PARP and SiR modulating activity as cytoprotective agents
JP4963359B2 (ja) * 2005-01-12 2012-06-27 ロート製薬株式会社 眼局所適用製剤
EP2097044A4 (fr) * 2006-12-26 2012-10-10 Quadra Logic Tech Inc Implants à libération de médicaments pour inhiber des défauts optiques
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
KR101571434B1 (ko) 2007-09-07 2015-11-24 마티 테라퓨틱스 인코포레이티드 치료 약제의 서방성 약물 코어
US8883214B2 (en) 2009-01-13 2014-11-11 The Regents Of The University Of California Implantable delivery vehicle for ocular delivery of muscarinic antagonists
PT2632468T (pt) * 2010-10-25 2018-03-02 Univ Manitoba Composições terapêuticas para polineuropatia diabética simétrica
RU2639472C2 (ru) * 2011-03-14 2017-12-21 Драг Деливери Солюшнз Лимитед Офтальмическая композиция
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
WO2016172712A2 (fr) 2015-04-23 2016-10-27 Sydnexis, Inc. Composition ophtalmique
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
JP2018521000A (ja) 2015-05-29 2018-08-02 シドネキシス，インク． Ｄ２ｏで安定化された医薬製剤
CN105663137A (zh) * 2016-01-14 2016-06-15 王真 哌仑西平在制备治疗脓毒症疾病的药物中的应用
WO2017204262A1 (fr) * 2016-05-25 2017-11-30 Singapore Health Services Pte Ltd Composition aqueuse contenant de l'atropine
CA3076457C (fr) * 2017-11-03 2023-09-19 Alcon Inc. Derives d'azabicyclo et de diazepine pour le traitement de troubles oculaires
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone
EA202192334A1 (ru) * 2019-03-26 2022-02-08 Винсантор, Инк. Составы для местного применения для лечения периферических невропатий
CN113993511A (zh) * 2019-06-10 2022-01-28 杰尼视界公司 用于治疗视力障碍的方法和制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US4865599A (en) * 1986-08-18 1989-09-12 Houston Biotechnology, Inc. Ophthalmic compositions for treating nerve degeneration
CA1336490C (fr) * 1988-06-03 1995-08-01 Paul Michael Iuvone Traitement pharmacologique de la croissance anormale de l'oeil
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
ES2136686T3 (es) * 1989-06-21 1999-12-01 Univ Pennsylvania Tratamiento y control de desarrollo ocular con agonistas colinergicos.
US5360801A (en) * 1989-06-21 1994-11-01 The Trustees Of The University Of Pennsylvania Pharmacological stimulation of eye growth
US5055302A (en) * 1990-02-22 1991-10-08 Trustees Of The University Of Pennsylvania Neuropeptide control of ocular growth
US5461808A (en) * 1993-02-08 1995-10-31 Fritts; Robert W. Table top backlit display
US5461052A (en) * 1993-04-30 1995-10-24 The Trustees Of The University Of Pennsylvania Prevention of myopia by tricyclic compounds
US5385939A (en) * 1993-04-30 1995-01-31 The Trustees Of The University Of Pennsylvania GABA-ergic modulation of eye growth
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
US6164282A (en) * 1999-01-27 2000-12-26 Allergan Sales, Inc. Methods for restoring and/or enhancing accommodation in pseudo phakia

Also Published As

Publication number Publication date
JP2004531569A (ja) 2004-10-14
IL158904A0 (en) 2004-05-12
HUP0304071A2 (hu) 2004-04-28
BR0210013A (pt) 2004-08-10
PL366924A1 (en) 2005-02-07
US20060188576A1 (en) 2006-08-24
US20040137069A1 (en) 2004-07-15
CA2447562A1 (fr) 2002-12-05
EP1397132A4 (fr) 2006-12-13
NZ529615A (en) 2005-07-29
ZA200309791B (en) 2004-10-04
RU2003136735A (ru) 2005-03-27
KR20040018380A (ko) 2004-03-03
ECSP044862A (es) 2004-03-23
WO2002096418A1 (fr) 2002-12-05
MXPA03010655A (es) 2007-06-22
RU2297831C2 (ru) 2007-04-27
EP1397132A1 (fr) 2004-03-17
CN1509172A (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
DE50204184D1 (de) Espressobrüheinrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE50208022D1 (de) Wischblatt
DE50206021D1 (de) Schlauchklemme
DE50103741D1 (de) Welle-Nabe-Verbindung
DE50204386D1 (de) Kreuztransducer
DE60225606D1 (de) Perfluoroelastomere
NO20035224D0 (no) Oftalmisk pirenzepingel
ATE335486T1 (de) Hydrazono-malonitrile
DE50209410D1 (de) Kugelgelenk
NO20014597D0 (no) Fremgangsmåte
DE50204551D1 (de) Kugelgelenk
DE50208372D1 (de) Schrankaufhängevorrichtung
DE50203412D1 (de) Schwenkkolbenverdränger
DE50204794D1 (de) Kugelgelenk
DE50203984D1 (de) Kugelgelenk
DE50211290D1 (de) Handzange
DE50208029D1 (de) Kugelgelenk
ATE355059T1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE50209293D1 (de) Amidpolymermasse
DE50209386D1 (de) Kugelgelenk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application